San – Jose, CA (PRWEB) 16 พฤศจิกายน 2011
On LinkedIn – worldwide incidence and prevalence of autoimmune diseases, the increase in the market of drugs used to treat these diseases is expected. grow in the near future, the key factors of this growth is the increased use of biologics, which offer higher prices than generics and a major source of income for producers. In addition to such factors as the demand for medical tubing and extensive product with superior performance and growth prospects are optimistic the company engaged in developing new drugs that still rely on high productivity and economic growth. Identification and convenient mode of drug administration to ensure the success of their products. The manufacturer of products on the market today will focus on further development of the product to maintain market share. .extension of current labels for biologics for autoimmune problems, many of Humira, Enbrel, Remicade, and some of the biologics, which arise as a blockbuster because of their high-profile performance. The demand is fueled by the introduction of new products, improving access to medicines and better penetration of drugs that are available. New products launched in the market to expand treatment options for patients who do not respond to existing treatments. These products are becoming increasingly popular as an alternative to traditional treatment options. .
, as defined by the new market research report related to the treatment of autoimmune, the U.S. remains the largest market at regional level. The incidence of aging U.S. population and an increase in autoimmune diseases is driving the U.S. market for biological therapies in the treatment of autoimmune diseases. Although the higher price compared with market logic, to benefit from the introduction of new biologics with superior versions for the treatment of common diseases. In addition, the drug authorities in Medicare Part D programs, market access of these drugs. The European market for the treatment of autoimmune diseases, is expected to grow at a compound annual 8.7% in the analysis.
.rheumatoid arthritis is one of the world’s largest market for the treatment of autoimmune diseases. The growth in the treatment of rheumatoid arthritis can be triggered by an aging population and increasing number of autoimmune rasstroystv.Sovokupny CAGR of 12% in the analysis of drugs, psoriasis is the fastest growing market in the treatment of autoimmune diseases. The global market of several drugs sclerosis will depend on the high unmet needs in the sector in terms of performance and security.
.Major players in the market
include Abbott Laboratories, Amgen Inc, Bayer AG, Biogen Idec Inc, Bristol – Myers Squibb, Elan Corporation, Eli Lilly and Co., F. Hoffmann – La Roche said. G. Chugai Pharmaceutical Co, Ltd, Genesis and Technology Co., Ltd, GlaxoSmithKline PLC Johnson & Johnson Inc, Merck & Co Inc, Merck Soro Uno SA, Novartis AG, Sanofi – Aventis SA. Shire PLC, Teva Pharmaceutical Industries Limited and UCB SA
.study for the treatment of autoimmune diseases: a report published by Global Business Analyst Global, Inc has a comprehensive monitoring of trends, issues, events, strategic industries and major companies around the pattern. The report contains the world market estimates and forecasts. (In millions of U.S. dollars) for the treatment of rheumatoid arthritis arthritis (biologics), multiple sclerosis, psoriasis, Crohn’s disease (biologics), and other geographic markets such as USA, Japan, Europe and the rest of the world.
.more information about this report, the market research coverage of the visit. http://www.strategyr.com/Autoimmune_Disease_Therapeutics_Market_ Report.asp
. industry analyst at Global, Inc
analysts Global, Inc (GIA) is a leading provider of marketing research is off – - was founded in 1987, the company now employs over 800 people worldwide in more than 1300 GIA Publications. full research reports and analysis of marketing + 40,000 and technological trends, when considering more than 126 000 companies around the world, serving more than 9,500 in 27 countries, GIA, which is known today as one. world’s largest companies and reputable market research.
our LinkedIn
.Analysts
industry worldwide, Inc
Phone />
Website: http://www.StrategyR.com/
### P>.
clear = “all”.
on Teva News .